Hydralazine 是一种口服有效、可透过血脑屏障的 DNA 甲基转移酶抑制剂,具有血管舒张、松弛动脉平滑肌、降血压的活性。Hydralazine 能通过介导 DNA 去甲基化重新激活沉默的抑癌基因,同时发挥神经保护和抗炎特性。
Cas No.:86-54-4
Sample solution is provided at 25 µL, 10mM.
Hydralazine is an orally active, blood-brain barrier-permeable DNA methyltransferase inhibitor with vasodilatory, arterial smooth muscle relaxant and hypotensive activities. Hydralazine reactivates silenced tumor suppressor genes via mediating DNA demethylation, while exerting neuroprotective and anti-inflammatory properties. Hydralazine inhibits NOS-2 (iNOS) and COX-2, and reduces the production of NO and PGEE2; meanwhile, Hydralazine scavenges reactive oxygen species and inhibits macrophage activation. Hydralazine alleviates motor dysfunction, neuropathic inflammatory pain, and formalin-induced somatic and emotional pain responses. In addition, Hydralazine directly induces DNA strand breaks and sister chromatid exchange, exhibiting certain mutagenic characteristics. Hydralazine has been widely used in studies on hypertension, various cancers (such as cervical cancer, leukemia), spinal cord injury and the mechanisms of inflammatory pain[1][2][3][4][5].
References:
[1]. Arce C, et al. Hydralazine target: from blood vessels to the epigenome. J Transl Med. 2006;4:10. Published 2006 Feb 28.
[2]. Leiro JM, et al. Antioxidant activity and inhibitory effects of hydralazine on inducible NOS/COX-2 gene and protein expression in rat peritoneal macrophages. Int Immunopharmacol. 2004;4(2):163-177.
[3]. de Flora S, et al. In vivo and in vitro genotoxicity of three antihypertensive hydrazine derivatives (hydralazine, dihydralazine, and endralazine). Environ Mutagen. 1982;4(5):605-619.
[4]. Park J, et al. Neuroprotective role of hydralazine in rat spinal cord injury-attenuation of acrolein-mediated damage. J Neurochem. 2014;129(2):339-349. [Content Brief]
[5]. Bai L, et al. Attenuation of mouse somatic and emotional inflammatory pain by hydralazine through scavenging acrolein and inhibiting neuronal activation. Pain Physician. 2012;15(4):311-326.
Hydralazine 是一种口服有效、可透过血脑屏障的 DNA 甲基转移酶抑制剂,具有血管舒张、松弛动脉平滑肌、降血压的活性。Hydralazine 能通过介导 DNA 去甲基化重新激活沉默的抑癌基因,同时发挥神经保护和抗炎特性。Hydralazine 可抑制 NOS-2 (iNOS) 和 COX-2,减少 NO 和 PGEE2 的生成;同时,清除活性氧、抑制巨噬细胞活化。Hydralazine 能够减轻运动功能障碍、神经性炎性疼痛以及福尔马林诱导的躯体和情绪性疼痛反应。此外,Hydralazine 可直接诱导 DNA 断裂和姐妹染色单体交换,表现出一定的诱变剂特征。Hydralazine 已被广泛应用于高血压、多种癌症 (如宫颈癌、白血病)、脊髓损伤及炎性疼痛机制的研究中。
| Cas No. | 86-54-4 | SDF | |
| 分子式 | C8H8N4 | 分子量 | 160.18 |
| 溶解度 | DMSO : 20 mg/mL (124.86 mM; Need ultrasonic(<60°C)) | 储存条件 | Store at -20°C |
| Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 | ||
| 制备储备液 | |||
![]() |
1 mg | 5 mg | 10 mg |
| 1 mM | 6.243 mL | 31.2149 mL | 62.4298 mL |
| 5 mM | 1.2486 mL | 6.243 mL | 12.486 mL |
| 10 mM | 624.3 μL | 3.1215 mL | 6.243 mL |
| 第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
| 给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
| 第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
| % DMSO % % Tween 80 % saline | ||||||||||
| 计算重置 | ||||||||||
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >99.50% Appearance: A solid
- COA (Certificate of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
















